U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 202123

COMPLERA (EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE)
200MG;EQ 25MG BASE;300MG
Marketing Status: Prescription
Active Ingredient: EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
Proprietary Name: COMPLERA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG;EQ 25MG BASE;300MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N202123
Product Number: 001
Approval Date: Aug 10, 2011
Applicant Holder Full Name: GILEAD SCIENCES INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top